WeVote
Log In

Bill

Bill

SB 789

Pharmacy benefit managers; permitting use of certain records without limitations of date or source for certain purposes; establishing certain reimbursement rates for certain drugs. Effective date.

2025 Regular Session Introduced by Todd Gollihare and 1 co-sponsor

Oklahoma law expands pharmacy benefit managers' record-access authority without restrictions and establishes new drug reimbursement rate frameworks, becoming law without gubernatorial signature.

Becomes law without Governor's signature 05/28/2025
0
WeVote Research Nonpartisan
Bill Summary · SB 789

Legislative bill overview

SB 789 modifies regulations governing pharmacy benefit managers (PBMs) in Oklahoma by allowing them to access certain records without date or source restrictions for specified purposes, and establishes new frameworks for reimbursement rates on certain drugs. The bill became law without the Governor's signature on May 28, 2025, following unanimous passage in the Oklahoma House.

Why is this important

PBMs are intermediaries that negotiate drug prices and manage pharmacy networks, making them powerful actors in healthcare costs. Changes to their record-access authority and reimbursement rate structures directly affect drug pricing, pharmacy profitability, and ultimately what consumers and insurance plans pay for medications. This legislation could influence medication affordability and pharmacy business operations across Oklahoma.

Potential points of contention

  • Record access scope: Permitting unrestricted access to records without date or source limitations could raise privacy concerns and may give PBMs broad investigative power that could disadvantage pharmacies or patients
  • Reimbursement rate mechanisms: The bill's specific reimbursement rate provisions are not detailed in available text, but PBM reimbursement changes often spark conflict between insurers, pharmacies, and drug manufacturers over profit margins
  • Lack of transparency: The bill's language is vague regarding which specific purposes justify record access and how reimbursement rates are determined, making real-world impact difficult to assess without regulatory guidance

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.